Article ; Online: Recent evidence of economic evaluation of artificial intelligence in ophthalmology.
Current opinion in ophthalmology
2023 Volume 34, Issue 5, Page(s) 449–458
Abstract: Purpose of review: Health economic evaluation (HEE) is essential for assessing value of health interventions, including artificial intelligence. Recent approaches, current challenges, and future directions of HEE of artificial intelligence in ... ...
Abstract | Purpose of review: Health economic evaluation (HEE) is essential for assessing value of health interventions, including artificial intelligence. Recent approaches, current challenges, and future directions of HEE of artificial intelligence in ophthalmology are reviewed. Recent findings: Majority of recent HEEs of artificial intelligence in ophthalmology were for diabetic retinopathy screening. Two models, one conducted in the rural USA (5-year period) and another in China (35-year period), found artificial intelligence to be more cost-effective than without screening for diabetic retinopathy. Two additional models, which compared artificial intelligence with human screeners in Brazil and Thailand for the lifetime of patients, found artificial intelligence to be more expensive from a healthcare system perspective. In the Thailand analysis, however, artificial intelligence was less expensive when opportunity loss from blindness was included. An artificial intelligence model for screening retinopathy of prematurity was cost-effective in the USA. A model for screening age-related macular degeneration in Japan and another for primary angle close in China did not find artificial intelligence to be cost-effective, compared with no screening. The costs of artificial intelligence varied widely in these models. Summary: Like other medical fields, there is limited evidence in assessing the value of artificial intelligence in ophthalmology and more appropriate HEE models are needed. |
---|---|
MeSH term(s) | Infant, Newborn ; Humans ; Ophthalmology ; Artificial Intelligence ; Diabetic Retinopathy/diagnosis ; Cost-Benefit Analysis ; Delivery of Health Care |
Language | English |
Publishing date | 2023-07-17 |
Publishing country | United States |
Document type | Review ; Journal Article |
ZDB-ID | 1049383-9 |
ISSN | 1531-7021 ; 1040-8738 |
ISSN (online) | 1531-7021 |
ISSN | 1040-8738 |
DOI | 10.1097/ICU.0000000000000987 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 3047: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.